Order Article Reprints

Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Palmisano A, Cucchiara V, Brembilla G, Bezzi C, Rigamonti R, Magnani P, et al. ⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data. Cancers. 2022; 14(2):334. https://doi.org/10.3390/cancers14020334

Mapelli, Paola, Samuele Ghezzo, Ana Maria Samanes Gajate, Erik Preza, Anna Palmisano, Vito Cucchiara, Giorgio Brembilla, Carolina Bezzi, Riccardo Rigamonti, Patrizia Magnani, and et al. 2022. "⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data" Cancers 14, no. 2: 334. https://doi.org/10.3390/cancers14020334

Mapelli, P., Ghezzo, S., Samanes Gajate, A. M., Preza, E., Palmisano, A., Cucchiara, V., Brembilla, G., Bezzi, C., Rigamonti, R., Magnani, P., Toninelli, E., Bettinardi, V., Suardi, N., Gianolli, L., Scifo, P., Briganti, A., De Cobelli, F., Esposito, A., & Picchio, M. (2022). ⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data. Cancers, 14(2), 334. https://doi.org/10.3390/cancers14020334